최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국방사선학회 논문지 = Journal of the Korean Society of Radiology, v.14 no.3, 2020년, pp.319 - 336
김원효 (동신대학교 방사선학과) , 김인수 (동신대학교 방사선학과) , 공창기 (동신대학교 방사선학과) , 한재복 (동신대학교 방사선학과)
The purpose of this study was to compare the outcomes of two interventional methods, overlapping drug-eluting stents (DES) and long DES, for long-term clinical outcomes in patients with acute myocardial infarction (AMI). A total of 438 patients with AMI (65.9±11.0 years, 306 males) from June ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
일반금속스텐트 시술의 문제점은 무엇인가? | 일반금속스텐트 시술은 풍선을 이용한 성형술의 치명적인 단점이었던 관상동맥의 급성 수축(Acute Recoil)과 재협착은 줄였지만, 일반금속스텐트가 관상동맥에 시술하게 되면 확장 과정에서 기계적인 혈관 손상이 발생하고 이는 혈관 평활근 세포의 증식 및 이주를 불러일으켜서 신생내막 형성(Neointimal Hyperplasia), 즉 스텐트 내 재협착 (In-Stent Restenosis, ISR) 발생과 아급성 혈전증(Subacute Stent Thrombosis)이라는 새로운 문제점을 야기시켰다. |
A. R. Gruntzig, A. Senning, W. E. Siegenthaler, "Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty", New England journal of medicine, Vol. 301, pp. 61-68, 1979. https://doi.org/10.1056/nejm197907123010201
W. Casscells, D. Engler, J. T. Willerson, "Mechanisms of restenosis", Texas Heart Institute Journal, Vol. 21, pp. 68-77, 1994. https://doi.org/10.1016/0735-1097(93)90241-R
P. W. Serruys, P. de Jaegere, F. Kiemeneij, C. Macaya, W. Rutsch, G. Heyndrickx, H. Emanuelsson, J. Marco, V. Legrand, P, Materne, J. Belardi, U. Sigwart, A. Colombo, J. J. Goy, P. van den Heuvel, J. Delcan, M. Morelet, "A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group", New England journal of medicine, Vol. 331, pp. 489-495, 1994. https://doi.org/10.1056/nejm199408253310801
D. L. Fischman, M. B. Leon, D. S. Baim, R. A. Schatz, M. P. Savage, I. Penn, K. Detre, L. Veltri, D. Ricci, M. Nobuyoshi, M. Cleman, R. Heuser, D. Almond, P. S. Teirstein, R. D. Fish, A. Colombo, J. Brinker, J. Moses, A. Shaknovich, J. Hirshfeld, S. Bailey, S, Ellis, R. Rake, S. Goldberget, "A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators", New England journal of medicine, Vol. 331, pp. 496-501, 1994. https://doi.org/10.1056/nejm199408253310802
S. J. Park, W. H. Shim, D, S. Ho, A. E. Raizner, S. W. Park, M. K. Hong, C. W. Lee, D. Choi, Y. Jang, R. Lam, N. J. Weissman, G. S. Mintz, "A paclitaxel-eluting stent for the prevention of coronary restenosis", New England journal of medicine, Vol. 348, pp. 1537-1545, 2003. https://doi.org/10.1056/nejmoa021007
E. Regar, G. Sianos, P. W. Serruys, "Stent development and local drug delivery", British Medical Bulletin, Vol. 59, pp. 227-248, 2001. https://doi.org/10.1093/bmb/59.1.227
H. Le Breton, E. F. Plow, E. J. Topol, "Role of platelets in restenosis after percutaneous coronary revascularization", Journal of the American College of Cardiology, Vol. 28, pp. 1643-1651, 1996. https://doi.org/10.1016/S0735-1097(96)00417-2
R. Virmani, G. Guagliumi, A. Farb, "Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious", Circulation, Vol. 109, pp. 701-705, 2004. https://doi.org/10.1161/01.cir.0000116202.41966.d4
H. Vaknin-Assa, A. Assali, S. Ukabi, E. I. Lev, R. Kornowski, "Stent thrombosis following drug-eluting stent implantation A single-center experience", Cardiovascular Revascularization Medicine, Vol. 8, pp. 243-247, 2007. https://doi.org/10.1016/j.carrev.2007.07.001
P. W Serruys, M. C. Morice, A. P. Kappetein, "Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease", New England journal of medicine Vol. 360, pp. 961-972. 2009. https://doi.org/10.1056/nejmoa0804626
C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M. C. Morice, A. Schomig, M. E. Pfisterer, G. W. Stone, M. B. Leon, J. S. de Lezo, "Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis", The Lancet, Vol. 370, pp. 937-948, 2007. https://doi.org/10.1016/s0140-6736(07)61444-5
A. Kaltoft, L. O. Jensen, M. Maeng, H. H. Tilsted, P. Thayssen, M. Bottcher, J. F. Lassen, L. R. Krusell, K. Rasmussen, K. N. Hansen, "2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)", Journal of the American College of Cardiology, Vol. 53, pp. 658-664, 2009. https://doi.org/10.1016/j.jacc.2008.09.058
S. K. James, U. Stenestrand, J. Lindback, J. Carlsson, F. Schersten, T. Nilsson, L. Wallentin, B. Lagerqvist, "Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden", New England journal of medicine, Vol. 360, pp.1933-1945, 2009. https://doi.org/10.1056/nejmoa0809902
S. B. King, S. C. Smith, J. W. Hirshfeld, A. K. Jacobs, D. A. Morrison, Williams DO; 2005 WRITING COMMITTEE MEMBERS, T. E. Feldman, M. J. Kern, W. W. O'Neill, "2007 Focused Update of the ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee", Circulation, Vol. 117, pp. 261-295, 2008. https://doi.org/10.1161/CIRCULATIONAHA.107.188208
A. Messori, S. Trippoli, "Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance", Heart, Vol. 95, pp. 84, 2009.
K. D. Dawkins, E. Grube, G. Guagliumi, A. P. Banning, K. Zmudka, A. Colombo, L. Thuesen, K. Hauptman, J. Marco, W. Wijns, J. J. Popma, J. Koglin, M. E. Russell, "Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice", Circulation, Vol. 112, pp. 3306-3313, 2005. https://doi.org/10.1161/circulationaha.105.552190
D. R. Holmes, M. B. Leon, J. W. Moses, J. J. Popma, D. Cutlip, M. Midei, D. Snead, R. E. Kuntz, "Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis", Circulation, Vol. 109, pp. 634-640, 2004. https://doi.org/10.1161/01.cir.0000112572.57794.22
A. V. Finn, F. D. Kolodgie, J. Harnek, L. J. Guerrero, E. Acampado, K. Tefera, K. Skorija, D. K. Weber, H. K. Gold, R. Virmani, "Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus or paclitaxel-eluting stents", Circulation, Vol. 112, pp. 270-278, 2005. https://doi.org/10.1161/circulationaha.104.508937
H. Doi, A. Maehara, G. S. Mintz, K. Tsujita, T. Kubo, C. Castellanos, J. Liu, J. Yang, C. Oviedo, J. Aoki, M. B. Leon, "Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture", The American Journal of Cardiology, Vol. 103, pp. 818-823, 2009. https://doi.org/10.1016/j.amjcard.2008.11.051
P. W. Serruys, D. P. Foley, M. J. Suttorp, "A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study", Journal of the American College of Cardiology, Vol. 39, pp. 393-399, 2002. https://doi.org/10.1016/s0735-1097(01)01760-0
I. Iakovou, T. Schmidt, E. Bonizzoni, "Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents", The Journal of the American Medical Association, Vol. 293, pp. 2126-2130, 2005. https://doi.org/10.1001/jama.293.17.2126
P. K. Kuchulakanti, W. W. Chu, R. Torguson R, "Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-eluting stents and paclitaxel-eluting stents", Circulation, Vol. 113, pp. 1108-1113, 2006. https://doi.org/10.1161/circulationaha.105.600155
A. V. Finn, F. D. Kolodgie, J. Harnek, "Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-eluting stents or paclitaxel-eluting stents", Circulation, Vol. 112, pp. 270-278, 2005. https://doi.org/10.1161/circulationaha.104.508937
L. Raber, P. Juni, L. Loffel, S. Wandel, S. Cook, P. Wenaweser, M. Togni, R. Vogel, C. Seiler, F. Eberli, T. Luscher, B. Meier, S. Windecker, "Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation", Journal of the American College of Cardiology, Vol. 55, pp. 1178-1188, 2010. https://doi.org/10.1016/j.jacc.2009.11.052
H. Kitabata, J. P. Loh, L. K. Pendyala, S. Badr, D. Dvir, I. M. Barbash, S. Minha, R. Torguson, F. Chen, L. F. Satler, W. O. Suddath, K. M. Kent, A. D. Pichard, R. Waksman, "Safety and efficacy outcomes of overlapping second generation everolimus-eluting stents versus first-generation drug eluting stents", The American Journal of Cardiology, Vol. 112, pp. 1093-1098, 2013. https://doi.org/10.1016/j.amjcard.2013.05.054
K. Ahmed, M. H. Jeong, R. Chakraborty, Y. J. Hong, D. S. Sim, S. Ahmed, S. H. Hwang, M. G. Lee, J. C. Par, J. C. Kang, "Safety and efficacy of overlapping homogenous drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction Registry", Journal of Korean Medical Science, Vol. 27, pp. 1339-1346, 2012. http://dx.doi.org/10.3346/jkms.2012.27.11.1339
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology(ESC), P. G. Steg, S. K. James, "ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation", European Heart Journal, Vol. 33, pp. 2569-2619, 2012. http://dx.doi.org/10.1093/eurheartj/ehs215
P. W. Serruys, M. C. Morice, A. P. Kappetein, "Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease", New England journal of medicine, Vol. 360, pp. 961-972, 2009. http://dx.doi.org/10.1056/NEJMoa0804626
E. Grube, L. Buellesfeld, "BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease", Expert Review of Medical Devices, Vol. 3, pp. 731-741, 2006. http://dx.doi.org/10.1586/17434440.3.6.731
M. Ostojic, D. Sagic, R. Jung, "The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study", Catheterization and Cardiovascular Interventions, Vol. 72, pp. 901-908, 2008. https://doi.org/10.1002/ccd.21775
T. Chechi, G. Vittori, G. G. Biondi Zoccai, "Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION)", Journal of Interventional Cardiology, Vol. 20, pp. 282-291, 2007. https://doi.org/10.1111/j.1540-8183.2007.00270.x
S. Bangalore, S. Kumar, M. Fusaro, "Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient years of follow-up from randomized trials", Circulation, Vol. 125, pp. 2873-2891, 2012. https://doi.org/10.1161/circulationaha.112.097014
K. Y. Chen, S. W. Rha, L. Wang, "Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity score-matched analysis", JACC Cardiovascular Interventions, Vol. 5, pp. 936-945, 2012. https://doi.org/10.1016/j.jcin.2012.05.009
M. Degertekin, C. A. Arampatzis, P. A. Lemos, "Very long sirolimus-eluting stent implantation for de novo coronary lesions", The American Journal of Cardiology, Vol. 93, pp. 826-829, 2004. https://doi.org/10.1016/j.armjcard.2003.12.018
W. Kim, M. H. Jeon, J. Y. Cho, "The preventive effect on instent restenosis of overlapped drug-eluting stents for diffuse coronary artery disease", Korean Circulation Journal, Vol. 36, pp. 17-1723, 2006. https://doi.org/10.4070/kcj.2006.36.1.17
B. Azarbal, J. W. Currier, "Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer", Journal of the American College of Cardiology, Vol. 47, pp. 182-183, 2006. https://doi.org/10.1016/j.jacc.2005.09.045
M. H. Shishehbor, R. Amini, R. E. Raymond, A. A. Bavry, S. J. Brener, S. R. Kapadia, P. L. Whitlow, S. G. Ellis, D. L. Bhatt, "Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents", American Heart Journal, Vol. 155, pp. 1075-1080, 2008. https://doi.org/10.1016/j.ahj.2008.01.017
M. Degertekin, C. A. Arampatzis, P. A. Lemos, F. Saia, A. Hoye, J. Daemen, K. Tanabe, C. H. Lee, S. J. Hofma, G. Sianos, "Very long sirolimus-eluting stent implantation for de novo coronary lesions", The American Journal of Cardiology, Vol. 93, pp. 826-829, 2004. https://doi.org/10.1016/j.amjcard.2003.12.018
P. W. Serruys, S. Silber, S. Garg, R. J. van Geuns, G. Richardt, P. E. Buszman, H. Kelbaek, A. J. van Boven, S. H. Hofma, A. Linke, "Comparison of zotarolimus-eluting and everolimus-eluting coronary stents", New England journal of medicine, Vol. 363, pp. 136-144, 2010. https://doi.org/10.1056/NEJMoa1004130
S. Y. Lim, M. H. Jeong, S. J. Hong, D. S. Lim, J. Y. Moon, Y. J. Hong, J. H. Kim, Y. K. Ahn, J. C. Kang, "Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis", Circulation Journal, Vol. 72, pp. 463-468, 2008. https://doi.org/10.1253/circj.72.463
V. Farooq, P. Vranckx, L. Mauri, D. E. Cutlip, J. Belardi, S. Silber, P. Widimsky, M. Leon, H. M. Garcia-Garcia, P. W. Serruys, "Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program", Heart, Vol. 99, pp. 626-633, 2013. https://doi.org/10.1136/heartjnl-2012-303368
C. J. O'Sullivan, G. G. Stefanini, L. Raber, D. Heg, M. Taniwaki, B. Kalesan, T. Pilgrim, T. Zanchin, P. Juni, S. Windecker, "Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents", EuroIntervention, Vol. 9, pp. 1076-1084, 2004. https://doi.org/10.4244/EIJV919A182
H. Otake, Y. Honda, M. Yamasaki, I. Tsujino, T. Shimohama, R. Sakurai, T. Hasegawa, K. Waseda, J. Ako, P. J. Fitzgerald, "Vascular Response to Overlapping Everolimus-Eluting Stents : Comparison With Paclitaxel-Eluting Stents", Circulation Journal, Vol. 74, pp. 1023-1025, 2010. https://doi.org/10.1253/circj.cj-10-0052
N. Mori, M. Nishino, D. Nakamura, Y. Lee, T. Yoshimura, M. Taniike, N. Makino, H. Kato, Y. Egami, R. Shutta, H. Morita, J. Tanouchi, Y. Yamada, "Different neointimal response to overlapping segments between everolimus-eluting stents and sirolimus-eluting stents-optical coherence tomographic study", Circulation, Vol. 124, pp. A12546, 2011. https://doi.org/10.1093/eurheartj/eht309.2673
A. J. Kirtane, A. Gupta, S. Iyengar, J. W. Moses, M. B. Leon, R. Applegate, B. Brodie, E. Hannan, K. Harjai, L. O. Jensen, "Safety and efficacy of drugeluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies", Circulation, Vol. 119, pp. 3198-3206, 2009. https://doi.org/10.1161/CIRCULATIONAHA.108.826479
N. Mori, N. Okamoto, A. Tanaka, M. Yano, N. Makino, Y. Egami, R. Shutta, Y. Sakata, J. Tanouchi, M. Nishino, "Comparison of Angiographic and 1-Year Outcomes Between a Long Single Stent and Overlapping Double Stents in Patients With Newer-Generation Drug-Eluting Stents for Long Narrowings", The American Journal of Cardiology, Vol. 117, pp. 1724-1728, 2016. https://doi.org/10.1016/j.amjcard.2016.03.004
K. Ahmed, M. H. Jeong, R. Chakraborty, "Comparison of zotarolimus- and everolimus-eluting stents in patients with ST-elevation myocardial infarction and chronic kidney disease undergoing primary percutaneous coronary intervention", Journal of Cardiology, Vol. 64, pp. 273-278. 2014. https://doi.org/10.1016/j.jjcc.2014.02.002
S. Windecker, P. W. Serruys, S. Wandel, "Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial", Lancet, Vol. 372, pp. 1163-1173, 2008. https://doi.org/10.1016/S0140-6736(08)61244-1
M. Natsuaki, K. Kozuma, T. Morimoto, H. Shiomi, T. Kimura, "Two-year outcome of a randomized trial comparing second generation drug-eluting stents using biodegradable or durable polymer", The Journal of the American Medical Association, Vol. 311, pp. 2125-2127, 2014. https://doi.org/10.1001/jama.2014.3584
G. G. Stefanini, R. A. Byrne, P. W. Serruys, "Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials", European Heart Journal, Vol. 33, pp. 1214-1222, 2012. https://doi.org/10.1093/eurheartj/ehs086
G. G. Stefanini, B. Kalesan, P. W. Serruys, "Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (leaders): 4 year follow-up of a randomised non-inferiority trial", The Lancet, Vol. 378, pp. 1940-1948, 2011. https://doi.org/10.1016/S0140-6736(11)61672-3
X. F. Tang, Y. L. Ma, Y. Song, J. J. Xu, Y. Yao, C. He, H. H. Wang, P. Jiang, L. Jiang, R. Liu, Z. Gao, X. Y. Zhao, S. B. Qiao, Y. J. Yang, R. L. Gao, B. Xu, J. Q. Yuan, "Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study", Cardiovasc Diabetol, Vol. 17, pp. 114, 2018. https://doi.org/10.1186/s12933-018-0758-0
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.